FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 196 filers reported holding FIBROGEN INC in Q2 2018. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,205,000 | -9.8% | 194,270 | 0.0% | 0.25% | -15.4% |
| Q3 2020 | $7,988,000 | +1.4% | 194,270 | 0.0% | 0.30% | -0.3% |
| Q2 2020 | $7,874,000 | +16.6% | 194,270 | 0.0% | 0.30% | -1.6% |
| Q1 2020 | $6,751,000 | -19.0% | 194,270 | 0.0% | 0.30% | -3.2% |
| Q4 2019 | $8,332,000 | -3.4% | 194,270 | -16.7% | 0.32% | -16.2% |
| Q3 2019 | $8,622,000 | -21.9% | 233,142 | -4.6% | 0.38% | -16.4% |
| Q2 2019 | $11,038,000 | +15.6% | 244,320 | +39.0% | 0.45% | +16.0% |
| Q1 2019 | $9,552,000 | -3.0% | 175,742 | -17.4% | 0.39% | -7.8% |
| Q4 2018 | $9,847,000 | -9.0% | 212,763 | +19.4% | 0.42% | +7.1% |
| Q3 2018 | $10,826,000 | -3.0% | 178,207 | 0.0% | 0.39% | -7.1% |
| Q2 2018 | $11,156,000 | +131.5% | 178,207 | +70.8% | 0.42% | +126.2% |
| Q1 2018 | $4,819,000 | – | 104,307 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |